The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 ...
On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...
RANCHO CORDOVA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) subsidiary Riize, LLC (Riize Health ...